Therapeutic effects of vitamin D supplementation on COVID-19 aggravation: a systematic review and meta-analysis of randomized controlled trials.

Autor:	Yang Y; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China., Sun W; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China., Yang F; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China., Zhang G; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China., Li X; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China., Sun S; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China., Xing Y; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Jazyk:	angličtina
Zdroj:	Frontiers in pharmacology [Front Pharmacol] 2024 May 27; Vol. 15, pp. 1367686. Date of Electronic Publication: 2024 May 27 (Print Publication: 2024).
DOI:	10.3389/fphar.2024.1367686
Abstrakt:	Background: The therapeutic effects of vitamin D supplementation on Coronavirus disease 2019 (COVID-19) aggravation remain controversial and inconclusive. To probe into this contentious issue, we performed the present meta-analysis of randomized controlled trials (RCTs). Methods: Literature published up to June 2023 was retrieved from Cochrane Library, PubMed, Web of Science and Embase. RCTs assessing mortality, intensive care unit (ICU) admission, mechanical ventilation (MV), length of hospitalization (LOH), and inflammatory markers containing C-reactive protein (CRP), D-dimer, interleukin-6 (IL-6), lactate dehydrogenase (LDH) were included. 19 RCTs were involved in the analysis and were conducted subgroup analyses on the baseline COVID-19 severity and vitamin D administration. Results: In the severity subgroup, statistically significant effects in moderate to severe group were observed in ICU admission (OR 0.43, 95% CI 0.23, 0.80; p = 0.008), MV (OR 0.44, 95% CI 0.27, 0.72; p = 0.001) and LOH (SMD -0.49, 95% CI -0.92, -0.06; p = 0.027). In the administration subgroup, effects of ICU admission (OR 0.39, 95% CI 0.16, 0.97; p = 0.044), MV (OR 0.18, 95% CI 0.07, 0.46; p = 0.000) and LOH (SMD -0.50, 95% CI -0.96, -0.04; p = 0.034) were more pronounced in patients supplied with multiple-dose vitamin D than single-dose. Although the result of mortality showed no statistically significant effect, it indicated a reduced trend (OR 0.87, 95% CI 0.63, 1.12; p > 0.05). The results of inflammatory markers reached no statistical differences. Conclusion: This meta-analysis revealed that moderate to severe COVID-19 patients supplied with multiple doses of vitamin D were less apt to need ICU admission, mechanical ventilation and have shorter hospital stays. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2024 Yang, Sun, Yang, Zhang, Li, Sun and Xing.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu